Assuming that normalization of CD4/CD8 ratio decreases the risk of non-AIDS events, our findings indicate that the current “test and treat” strategy adopted by some countries (including Brazil) to fight AIDS probably will reduce the proportion of treated patients failing to achieve an adequate immune restoration, once the early treatment will increase their chances to meet that goal. The gene discussed is CD4; the disease is AIDS.